XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Foreign Exchange Contract
Interest Rate Swap
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Foreign Exchange Contract
Accumulated Other Comprehensive Loss
Interest Rate Swap
Noncontrolling Interests
Beginning balance outstanding (in shares) at Dec. 31, 2018       0 143,205,394            
Balance at beginning of period at Dec. 31, 2018 $ 1,431.2     $ 0.0 $ 0.0 $ 1,744.6 $ (56.4) $ (441.5)     $ 184.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Cumulative preferred stock (in shares)       300,000              
Cumulative preferred stock 295.2     $ 295.2              
Restricted stock grants (RSG) (in shares)         64,458            
Shares retired due to RSG vesting (in shares)         (764,909)            
Shares retired due to RSG Vesting (16.4)         (16.4)          
Shares retired due to common stock repurchase program (in shares)         (221,834)            
Shares retired due to common stock repurchase program (4.3)         (3.9) (0.4)        
Stock based compensation 30.2         30.2          
Other comprehensive income (loss):                      
Unrealized foreign currency translation gain, net of tax 6.3             (4.3)     10.6
Unrealized currency derivative contracts gain (loss)   $ 29.3 $ (0.7)           $ 29.3 $ (0.7)  
Common stock dividends (121.1)           (121.1)        
Net income 321.1           226.7       94.4
Contributions from noncontrolling interests 15.0                   15.0
Distributions to noncontrolling interests (264.0)                   (264.0)
Ending balance outstanding (in shares) at Dec. 31, 2019       300,000 142,283,109            
Balance at end of period at Dec. 31, 2019 1,719.2     $ 295.2 $ 0.0 1,754.5 46.2 (417.2)     40.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Shares forfeited (in shares)         (62,710)            
Restricted stock grants (RSG) (in shares)         2,543,551            
Shares retired due to RSG vesting (in shares)         (571,983)            
Shares retired due to RSG Vesting (11.6)         (11.6)          
Shares retired due to common stock repurchase program (in shares)         (2,826,644)            
Shares retired due to common stock repurchase program         $ (45.8) (50.0) 4.2        
Stock based compensation 32.3         32.3          
Other comprehensive income (loss):                      
Unrealized foreign currency translation gain, net of tax 66.7             66.1     0.6
Unrealized currency derivative contracts gain (loss)   (37.8) (4.7)           (37.8) (4.7)  
Common stock dividends (125.6)           (125.6)        
Preferred stock dividends (17.2)           (17.2)        
Net income 107.8           110.1       (2.3)
Contributions from noncontrolling interests 4.5                   4.5
Distributions to noncontrolling interests (18.9)                   (18.9)
Ending balance outstanding (in shares) at Dec. 31, 2020       300,000 141,365,323            
Balance at end of period at Dec. 31, 2020 1,672.7     $ 295.2 $ 0.0 1,725.2 17.7 (393.6)     28.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Shares forfeited (in shares)         (237,588)            
Restricted stock grants (RSG) (in shares)         619,945            
Shares retired due to RSG vesting (in shares)         (967,536)            
Shares retired due to RSG Vesting (20.5)         (20.5)          
Shares retired due to common stock repurchase program (in shares)         (2,824,665)            
Shares retired due to common stock repurchase program (62.7)         (50.0) (12.7)        
Stock based compensation         $ 28.7 28.7          
Other comprehensive income (loss):                      
Unrealized foreign currency translation gain, net of tax (56.6)             (55.8)     (0.8)
Unrealized currency derivative contracts gain (loss)   $ 56.1 $ 3.7           $ 56.1 $ 3.7  
Common stock dividends (125.8)           (125.8)        
Preferred stock dividends (17.2)           (17.2)        
Net income 336.4           330.4       6.0
Contributions from noncontrolling interests 7.8                   7.8
Distributions to noncontrolling interests (18.7)                   (18.7)
Incentive allocations to noncontrolling interests 0.0         (3.8)         3.8
Ending balance outstanding (in shares) at Dec. 31, 2021       300,000 137,955,479            
Balance at end of period at Dec. 31, 2021 $ 1,803.9     $ 295.2 $ 0.0 $ 1,679.6 $ 192.4 $ (389.6)     $ 26.3